AdaptHealth Reports Fourth Quarter and Full-Year 2021 Results and Updates 2022 Guidance

Go back to AdaptHealth Reports Fourth Quarter and Full-Year 2021 Results and Updates 2022 Guidance

AdaptHealth (AHCO) PT Lowered to $20 at Stifel

February 24, 2022 1:50 PM EST

Stifel analyst Mathew Blackman lowered the price target on AdaptHealth (NASDAQ: AHCO) to $20.00 (from $40.00) while maintaining a Buy rating.

... More

AdaptHealth Corp. (AHCO) Misses Q4 EPS by 19c, Revenue Beats, Offers Guidance

February 24, 2022 6:44 AM EST

AdaptHealth Corp. (NASDAQ: AHCO) reported Q4 EPS of $0.15, $0.19 worse than the analyst estimate of $0.34. Revenue for the quarter came in at $702.1 million versus the consensus estimate of $689.66 million.

GUIDANCE:

AdaptHealth Corp. sees FY2022 revenue of $2.825-3.025 billion, versus the consensus of... More